CDC Finds 92% Rise in Pediatric Carbapenemase‑Producing CRE, Led by NDM

The briefing

A CDC review of Antimicrobial Resistance Laboratory Network data shows a 92% increase in carbapenemase‑producing CRE among U.S. children from 2019 to 2024, largely driven by NDM‑producing organisms. The findings highlight growing pediatric antimicrobial resistance and the need for strengthened infection prevention and stewardship.